- Home
- RELL vs RNA Comparison
RELL vs RNA Comparison
Compare RELL & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELL | RNA |
|---|---|---|
| Founded | 1947 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.7M | 211.6M |
| IPO Year | 2004 | 2025 |
Fundamental Metrics
Financial Performance| Metric | RELL | RNA |
|---|---|---|
| Price | $18.94 | $13.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 20 |
| Target Price | N/A | ★ $69.26 |
| AVG Volume (30 Days) | 175.6K | ★ 211.0K |
| Earning Date | 04-08-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.75% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $208,909,000.00 | N/A |
| Revenue This Year | $6.32 | $88.12 |
| Revenue Next Year | $7.91 | $18.11 |
| P/E Ratio | $230.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.37 | $11.40 |
| 52 Week High | $19.86 | $73.06 |
Technical Indicators
Market Signals| Indicator | RELL | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 55.62 |
| Support Level | $10.17 | $12.72 |
| Resistance Level | $19.51 | $14.05 |
| Average True Range (ATR) | 0.88 | 0.51 |
| MACD | 0.03 | 0.18 |
| Stochastic Oscillator | 83.36 | 79.56 |
Price Performance
Historical ComparisonAbout RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
About RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.